The bottom line: if you're using Melanotan-1 for research purposes and you're not dosing in the morning, you're either accepting reduced efficiency or you have a specific contraindication that makes morning administration impractical
A., Partridge, L., Serrano, M., & Kroemer, G
Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I
pharmacokinetic study published in the European Journal of Clinical Pharmacology , which examined how orally administered glutathione is absorbed and processed
GLP-1 medications are not a cure-all and are not appropriate for every patient
Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8 + T cells in tumors